• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭伴射血分数降低与 COVID-19:在大流行期间,病情加重的患者更易受到影响:揭示种族和民族不平等现象。

Heart Failure with Reduced Ejection Fraction and COVID-19, when the Sick Get Sicker: Unmasking Racial and Ethnic Inequities During a Pandemic.

机构信息

Division of Cardiovascular Medicine, The Mount Sinai Health System, 1190 5th Avenue, 1st Floor, New York, NY 10029, USA.

Department of Biofunction Research, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan.

出版信息

Cardiol Clin. 2023 Nov;41(4):491-499. doi: 10.1016/j.ccl.2023.06.006. Epub 2023 Jun 15.

DOI:10.1016/j.ccl.2023.06.006
PMID:37743072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10267502/
Abstract

Minoritized racial and ethnic groups have the highest incidence, prevalence, and hospitalization rate for heart failure. Despite improvement in medical therapies and overall survival, the morbidity and mortality of these groups remain elevated. The reasons for this disparity are multifactorial, including social determinant of health (SDOH) such as access to care, bias, and structural racism. These same factors contributed to higher rates of COVID-19 infection among minoritized racial and ethnic groups. In this review, we aim to explore the lessons learned from the COVID-19 pandemic and its interconnection between heart failure and SDOH. The pandemic presents a window of opportunity for achieving greater equity in the health care of all vulnerable populations.

摘要

少数族裔群体的心力衰竭发病率、患病率和住院率最高。尽管医疗技术和整体存活率有所提高,但这些群体的发病率和死亡率仍然居高不下。造成这种差异的原因是多方面的,包括健康的社会决定因素(如获得医疗保健的机会、偏见和结构性种族主义)。这些相同的因素导致少数族裔群体 COVID-19 感染率更高。在这篇综述中,我们旨在探讨从 COVID-19 大流行中吸取的经验教训及其与心力衰竭和社会决定因素之间的联系。大流行为所有弱势群体的医疗保健实现更大公平提供了一个机会之窗。

相似文献

1
Heart Failure with Reduced Ejection Fraction and COVID-19, when the Sick Get Sicker: Unmasking Racial and Ethnic Inequities During a Pandemic.心力衰竭伴射血分数降低与 COVID-19:在大流行期间,病情加重的患者更易受到影响:揭示种族和民族不平等现象。
Cardiol Clin. 2023 Nov;41(4):491-499. doi: 10.1016/j.ccl.2023.06.006. Epub 2023 Jun 15.
2
Heart Failure with Reduced Ejection Fraction and COVID-19, when the Sick Get Sicker: Unmasking Racial and Ethnic Inequities During a Pandemic.心力衰竭伴射血分数降低与 COVID-19,病者更病:大流行期间种族和民族不平等现象的暴露。
Heart Fail Clin. 2024 Oct;20(4):353-361. doi: 10.1016/j.hfc.2024.06.002.
3
Racial and Ethnic Disparities in Hospitalization Outcomes Among Medicare Beneficiaries During the COVID-19 Pandemic.医疗保险受益人群在新冠疫情期间住院结局的种族和民族差异。
JAMA Health Forum. 2021 Dec 23;2(12):e214223. doi: 10.1001/jamahealthforum.2021.4223. eCollection 2021 Dec.
4
Assessment of Structural Barriers and Racial Group Disparities of COVID-19 Mortality With Spatial Analysis.利用空间分析评估 COVID-19 死亡率的结构性障碍和种族群体差异。
JAMA Netw Open. 2022 Mar 1;5(3):e220984. doi: 10.1001/jamanetworkopen.2022.0984.
5
Racial and ethnic disparities in heart failure: current state and future directions.心力衰竭中的种族和民族差异:现状和未来方向。
Curr Opin Cardiol. 2021 May 1;36(3):320-328. doi: 10.1097/HCO.0000000000000855.
6
Racial and ethnic disparities in viral acute respiratory infections in the United States: protocol of a systematic review.美国病毒性急性呼吸道感染中的种族和民族差异:系统评价方案。
Syst Rev. 2021 Jul 2;10(1):196. doi: 10.1186/s13643-021-01749-8.
7
Considerations in Addressing Social Determinants of Health to Reduce Racial/Ethnic Disparities in Stroke Outcomes in the United States.考虑解决健康社会决定因素,以减少美国中风结局的种族/民族差异。
Stroke. 2020 Nov;51(11):3433-3439. doi: 10.1161/STROKEAHA.120.030426. Epub 2020 Oct 26.
8
Disproportionate Impact of COVID-19 Pandemic on Racial and Ethnic Minorities.**译文**:COVID-19 大流行对少数族裔的不成比例影响。
Am Surg. 2020 Dec;86(12):1615-1622. doi: 10.1177/0003134820973356. Epub 2020 Nov 24.
9
Racial and ethnic disparities in excess mortality among U.S. veterans during the COVID-19 pandemic.美国新冠疫情期间退伍军人超额死亡率的种族和民族差异。
Health Serv Res. 2023 Jun;58(3):642-653. doi: 10.1111/1475-6773.14112. Epub 2022 Dec 30.
10
COVID-19 Health Disparities and Adverse Social Determinants of Health.COVID-19 健康差异和不良社会健康决定因素。
Behav Med. 2022 Apr-Jun;48(2):133-140. doi: 10.1080/08964289.2021.1990007. Epub 2022 Mar 23.

引用本文的文献

1
Return to Play after SARS-CoV-2 Infection: Focus on the Pediatric Population with Potential Heart Involvement.新型冠状病毒感染后重返运动:关注可能存在心脏受累的儿科人群。
J Clin Med. 2023 Oct 29;12(21):6823. doi: 10.3390/jcm12216823.

本文引用的文献

1
Cluster-Randomized Trial Comparing Ambulatory Decision Support Tools to Improve Heart Failure Care.比较门诊决策支持工具以改善心力衰竭护理的整群随机试验。
J Am Coll Cardiol. 2023 Apr 11;81(14):1303-1316. doi: 10.1016/j.jacc.2023.02.005. Epub 2023 Mar 5.
2
Community engagement and clinical trial diversity: Navigating barriers and co-designing solutions-A report from the "Health Equity through Diversity" seminar series.社区参与和临床试验多样性:克服障碍和共同设计解决方案——来自“通过多样性实现健康公平”研讨会系列的报告。
PLoS One. 2023 Feb 16;18(2):e0281940. doi: 10.1371/journal.pone.0281940. eCollection 2023.
3
Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association.
《心脏病与卒中统计数据-2023 更新:美国心脏协会报告》。
Circulation. 2023 Feb 21;147(8):e93-e621. doi: 10.1161/CIR.0000000000001123. Epub 2023 Jan 25.
4
Life expectancy loss among Native Americans during the COVID-19 pandemic.新冠疫情期间美国原住民的预期寿命损失
Demogr Res. 2022 Jul-Dec;47:233-246. doi: 10.4054/demres.2022.47.9. Epub 2022 Jul 27.
5
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial.升阶梯治疗急性心力衰竭指南导向的药物治疗的安全性、耐受性和疗效(STRONG-HF):一项多中心、开放标签、随机试验。
Lancet. 2022 Dec 3;400(10367):1938-1952. doi: 10.1016/S0140-6736(22)02076-1. Epub 2022 Nov 7.
6
Examining Disparities and Excess Cardiovascular Mortality Before and During the COVID-19 Pandemic.探讨 COVID-19 大流行前后心血管疾病死亡率的差异和过度情况。
Mayo Clin Proc. 2022 Dec;97(12):2206-2214. doi: 10.1016/j.mayocp.2022.07.008. Epub 2022 Jul 21.
7
Racial Inequities in Access to Ventricular Assist Device and Transplant Persist After Consideration for Preferences for Care: A Report From the REVIVAL Study.种族不平等在考虑护理偏好后仍然存在于心室辅助装置和移植的获得中:REVIVAL 研究的报告。
Circ Heart Fail. 2023 Jan;16(1):e009745. doi: 10.1161/CIRCHEARTFAILURE.122.009745. Epub 2022 Oct 19.
8
Medical therapy for patients with recent-onset heart failure with reduced ejection fraction during the COVID-19 pandemic: Insights from the Veteran's affairs healthcare system.COVID-19大流行期间射血分数降低的近期发病心力衰竭患者的药物治疗:来自退伍军人事务医疗系统的见解
Am Heart J Plus. 2022 Oct;22:100210. doi: 10.1016/j.ahjo.2022.100210. Epub 2022 Sep 17.
9
Association Between the Affordable Care Act Medicaid Expansion and Receipt of Cardiac Resynchronization Therapy by Race and Ethnicity.平价医疗法案医疗补助扩张与按种族和族裔划分的心脏再同步治疗的获得情况之间的关联。
J Am Heart Assoc. 2022 Oct 4;11(19):e026766. doi: 10.1161/JAHA.122.026766. Epub 2022 Sep 21.
10
Unequitable Heart Failure Therapy for Black, Hispanic and American-Indian Patients.针对黑人、西班牙裔和美国印第安患者的心力衰竭治疗不公平。
Card Fail Rev. 2022 Jul 7;8:e25. doi: 10.15420/cfr.2022.02. eCollection 2022 Jan.